Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1614050rdf:typepubmed:Citationlld:pubmed
pubmed-article:1614050lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:1614050lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:1614050pubmed:issue5lld:pubmed
pubmed-article:1614050pubmed:dateCreated1992-7-24lld:pubmed
pubmed-article:1614050pubmed:abstractTextClinical studies have demonstrated a poor correlation between localization tests, which are designed to determine the site of urinary tract infection, and symptoms of upper urinary tract infection. One explanation is that microorganisms may be present in the kidney but not initiate an inflammatory response with associated symptoms. An animal model has been developed to obtain quantitative information on the comparative pathobiology of lesion-inducing and non-lesion-inducing infections. In this model, non-manipulated kidneys had acquired a persistent microbial flora within 48 hours of the lower urinary tract becoming infected. This bacterial invasion was not associated with gross or histologic changes within the renal parenchyma, but minor foci of inflammatory cells were seen beneath the epithelium lining the calyces. Ureteric urines from such kidneys contained many leukocytes and high numbers of bacteria. These results showed that the kidneys were infected, rather than colonized, and the term "subclinical" infection was appropriate. Antimicrobial agents were variably successful at eradicating the infection. These experimental observations support the concept of subclinical pyelonephritis and may explain the absence of symptoms in the clinically equivalent situation in humans.lld:pubmed
pubmed-article:1614050pubmed:languageenglld:pubmed
pubmed-article:1614050pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1614050pubmed:citationSubsetIMlld:pubmed
pubmed-article:1614050pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1614050pubmed:statusMEDLINElld:pubmed
pubmed-article:1614050pubmed:monthMaylld:pubmed
pubmed-article:1614050pubmed:issn0085-2538lld:pubmed
pubmed-article:1614050pubmed:authorpubmed-author:GavinJ BJBlld:pubmed
pubmed-article:1614050pubmed:authorpubmed-author:MillerT ETElld:pubmed
pubmed-article:1614050pubmed:authorpubmed-author:RainerS PSPlld:pubmed
pubmed-article:1614050pubmed:authorpubmed-author:FindonGGlld:pubmed
pubmed-article:1614050pubmed:issnTypePrintlld:pubmed
pubmed-article:1614050pubmed:volume41lld:pubmed
pubmed-article:1614050pubmed:ownerNLMlld:pubmed
pubmed-article:1614050pubmed:authorsCompleteYlld:pubmed
pubmed-article:1614050pubmed:pagination1356-65lld:pubmed
pubmed-article:1614050pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:meshHeadingpubmed-meshheading:1614050-...lld:pubmed
pubmed-article:1614050pubmed:year1992lld:pubmed
pubmed-article:1614050pubmed:articleTitleThe pathobiology of subclinical pyelonephritis--an experimental evaluation.lld:pubmed
pubmed-article:1614050pubmed:affiliationDepartment of Medicine, University of Auckland, New Zealand.lld:pubmed
pubmed-article:1614050pubmed:publicationTypeJournal Articlelld:pubmed